Skip to main content
. 2022 Mar 30;14(4):747. doi: 10.3390/pharmaceutics14040747

Figure 10.

Figure 10

Viability of CCL-1 cells. Legend: (A). After exposure to solution containing empty niosomes (30 µmol/mL total lipid). (B). After exposure to hybrid in situ niosomal gels based on simultaneously loaded Curc/GS niosomes.